0001209191-23-024348.txt : 20230414 0001209191-23-024348.hdr.sgml : 20230414 20230414165803 ACCESSION NUMBER: 0001209191-23-024348 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230412 FILED AS OF DATE: 20230414 DATE AS OF CHANGE: 20230414 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cline Darren S CENTRAL INDEX KEY: 0001633639 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40353 FILM NUMBER: 23821863 MAIL ADDRESS: STREET 1: 35 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMPEL PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001445499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263058238 STATE OF INCORPORATION: DE FISCAL YEAR END: 0426 BUSINESS ADDRESS: STREET 1: 201 ELLIOTT AVE. W STREET 2: SUITE 260 CITY: SEATTLE STATE: WA ZIP: 98119 BUSINESS PHONE: 206-568-1466 MAIL ADDRESS: STREET 1: 201 ELLIOTT AVE. W STREET 2: SUITE 260 CITY: SEATTLE STATE: WA ZIP: 98119 FORMER COMPANY: FORMER CONFORMED NAME: IMPEL NEUROPHARMA INC DATE OF NAME CHANGE: 20080917 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-04-12 0 0001445499 IMPEL PHARMACEUTICALS INC IMPL 0001633639 Cline Darren S C/O IMPEL PHARMACEUTICALS INC. 201 ELLIOTT AVE W, STE 260 SEATTLE WA 98119 1 0 0 0 0 Stock Option (right to buy) 1.42 2023-04-12 4 A 0 20013 0.00 A 2033-04-11 Common Stock 20013 20013 D The option vests as to 1/3rd of the total shares on April 12, 2024 and then 1/36th of the total shares vests on each monthly anniversary thereafter, with 100% of the total shares vested and exercisable on April 12, 2026, subject to the reporting person's provision of service to the issuer on each vesting date. /s/ Adrian Adams as attorney-in-fact 2023-04-14